Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ONC201 and Nivolumab in MSS Metastatic Colorectal Cancer
NCT03791398Phase 2Terminated
- Sponsor
- Brown University
- Start
- Nov 2019
- Primary completion
- Jun 2021
- Modality
- Allosteric Modulators, Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, open-label trial of dordaviprone in colorectal cancer (metastatic) (mCRC), sponsored by Brown University. Started Nov 2019; status: terminated.
02
Drugs
dordaviprone
03
Conditions
colorectal cancer (metastatic) (mCRC)
Beyond the preview
Go deeper on NCT03791398.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03791398.